Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical and phase I results presented for MLN-4924

July 2, 2012

Japanese authorities approve Inlyta tablets

June 29, 2012

Astellas' Gonax approved in Japan

June 29, 2012

SymBio opens enrollment in Japanese rigosertib trial

June 29, 2012

Compugen shows potential of another B7/CD28-like protein target

June 29, 2012

Synta reports on interim analysis of GALAXY trial

June 29, 2012

Lilly presents novel MAP kinase p38 inhibitors

June 29, 2012

Novel PARP inhibitors developed in China

June 29, 2012

FDA grants priority review to NDA for regorafenib

June 29, 2012

Merrimack adds third arm to phase III trial in metastatic pancreatic cancer

June 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...